Literature DB >> 27125978

Increased GSK-3β expression in DRG microglia in response to sciatic nerve crush.

Wenjie Tang1, Bing Li1, Sheng Chen2, Ying Lu1, Ning Han2, Xia Li2, Zengchun Li3, Youzhen Wei4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27125978      PMCID： PMC4913518          DOI： 10.1093/abbs/gmw027

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN： 1672-9145            Impact factor:   3.848


× No keyword cloud information.
  10 in total

1.  Modulation of MAPK and Akt signaling pathways in proximal segment of injured sciatic nerves.

Authors:  Guixin Sun; Zengchun Li; Xinhong Wang; Wenjie Tang; Youzhen Wei
Journal:  Neurosci Lett       Date:  2012-12-28       Impact factor: 3.046

2.  GSK3β expression and phosphorylation during neuronal maturation in the rat dorsal root ganglion.

Authors:  Wenjie Tang; Ning Han; Yangzhou Liu; Zengchun Li; Youzhen Wei
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes.

Authors:  E Beurel; R S Jope
Journal:  Neuroscience       Date:  2010-05-27       Impact factor: 3.590

Review 4.  Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance.

Authors:  Yeong-Ray Wen; Ping-Heng Tan; Jen-Kun Cheng; Yen-Chin Liu; Ru-Rong Ji
Journal:  J Formos Med Assoc       Date:  2011-08       Impact factor: 3.282

5.  Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.

Authors:  Servio H Ramirez; Shongshan Fan; Ming Zhang; Anil Papugani; Nancy Reichenbach; Holly Dykstra; Aaron J Mercer; Ronald F Tuma; Yuri Persidsky
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

6.  Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action.

Authors:  L Mazzardo-Martins; D F Martins; J Stramosk; F J Cidral-Filho; A R S Santos
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

Review 7.  Importance of glial activation in neuropathic pain.

Authors:  Joanna Mika; Magdalena Zychowska; Katarzyna Popiolek-Barczyk; Ewelina Rojewska; Barbara Przewlocka
Journal:  Eur J Pharmacol       Date:  2013-03-13       Impact factor: 4.432

Review 8.  Contribution of the activation of satellite glia in sensory ganglia to pathological pain.

Authors:  Mamoru Takeda; Masayuki Takahashi; Shigeji Matsumoto
Journal:  Neurosci Biobehav Rev       Date:  2009-01-09       Impact factor: 8.989

9.  Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.

Authors:  Christopher J Yuskaitis; Richard S Jope
Journal:  Cell Signal       Date:  2008-10-29       Impact factor: 4.315

10.  Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition.

Authors:  Francois Renault-Mihara; Hiroyuki Katoh; Takeshi Ikegami; Akio Iwanami; Masahiko Mukaino; Akimasa Yasuda; Satoshi Nori; Yo Mabuchi; Hirobumi Tada; Shinsuke Shibata; Ken Saito; Masayuki Matsushita; Kozo Kaibuchi; Seiji Okada; Yoshiaki Toyama; Masaya Nakamura; Hideyuki Okano
Journal:  EMBO Mol Med       Date:  2011-10-18       Impact factor: 12.137
  10 in total
  3 in total

1.  Tau protein function: The mechanical exploration of axonal transport disorder caused by persistent pressure in dorsal root ganglia.

Authors:  Lei Zhang; Jun Fu; Xin-Hua Cheng; Li Tang
Journal:  Mol Genet Genomic Med       Date:  2019-01-29       Impact factor: 2.183

2.  Dexmedetomidine Alleviates Neuropathic Pain via the TRPC6-p38 MAPK Pathway in the Dorsal Root Ganglia of Rats.

Authors:  Songchao Xu; Yusheng Yi; Yanting Wang; Pei Wang; Yang Zhao; Wei Feng
Journal:  J Pain Res       Date:  2022-08-19       Impact factor: 2.832

3.  The Potential Role of Glycogen Synthase Kinase-3β in Neuropathy-Induced Apoptosis in Spinal Cord.

Authors:  Mina Rashvand; Samira Danyali; Homa Manaheji
Journal:  Basic Clin Neurosci       Date:  2020-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.